List of insiders holdings for Roivant Sciences Ltd.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Dexcel Pharma Technologies Ltd. Dexxon Holdings Ltd. Oren Dan 10% Owner | 2024-02-14 06:51:31 | 102,849,443 0 | 102,849,443 | Form 13G |
| Ramaswamy Vivek 10% Owner | 2024-04-12 18:01:26 | 94,527,290 0 | 94,527,290 | Form 3 |
| SVF Investments (UK) Ltd SoftBank Vision Fund L.P. SVF GP (Jersey) Ltd SVF Holdings (UK) LLP SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 2024-02-13 17:00:42 | 73,031,667 0 | 73,031,667 | Form 13G |
| SVF Investments (UK) Ltd SVF Holdings (UK) LLP SoftBank Vision Fund L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 2024-02-13 17:00:42 | 73,031,667 0 | 73,031,667 | Form 13G |
| VIKING GLOBAL INVESTORS LP Ott David C. HALVORSEN OLE ANDREAS Shabet Rose Sharon Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities Parent GP LLC 10% Owner | 2024-02-14 10:20:49 | 69,368,961 0 | 69,368,961 | Form 13G |
| QVT Financial LP QVT Financial GP LLC Director by Deputization Director 10% Owner | 2024-03-07 17:33:56 | 66,719,779 0 | 66,719,779 | Form 13G |
| QVT Financial LP Director by Deputization Director | 2024-09-26 21:22:44 | 0 65,793,779 | 65,793,779 | Form 4 |
| Gold Daniel Allen Director | 2024-09-26 20:34:13 | 4,731,830 22,179,358 | 26,911,188 | Form 4 |
| Sukhatme Mayukh Pres&Chief Investment Officer | 2024-07-30 21:02:52 | 22,488,532 1,657,698 | 24,146,230 | Form 4 |
| Gline Matthew CEO | 2024-10-22 21:00:27 | 17,361,059 0 | 17,361,059 | Form 4 |
| Venker Eric President & COO | 2024-10-22 21:00:30 | 13,043,704 0 | 13,043,704 | Form 4 |
| VIKING GLOBAL PERFORMANCE LLC Ott David C. HALVORSEN OLE ANDREAS Shabet Rose Sharon Viking Global Equities Master Ltd. Viking Global Equities II LP Viking Long Fund Master Ltd. Viking Long Fund GP LLC 10% Owner | 2023-06-26 17:10:14 | 0 12,884,307 | 12,884,307 | Form 4 |
| Zimmer Benjamin President, Roivant Health | 2021-10-01 17:41:04 | 4,768,874 0 | 4,768,874 | Form 3 |
| MANCHESTER KEITH S Director | 2024-09-26 20:35:40 | 1,277,178 0 | 1,277,178 | Form 4 |
| Machado Patrick Director | 2021-10-01 17:43:55 | 609,095 0 | 609,095 | Form 3 |
| Pulik Richard CFO | 2024-10-30 21:00:19 | 278,942 0 | 278,942 | Form 4 |
| Kumar Rakhi Chief Accounting Officer | 2024-10-22 21:00:28 | 208,366 0 | 208,366 | Form 4 |
| Lo Andrew Director | 2022-09-19 21:53:32 | 123,992 0 | 123,992 | Form 4 |
| Oren Ilan Director | 2024-10-23 21:00:19 | 97,856 0 | 97,856 | Form 4 |
| MOMTAZEE JAMES C Director | 2024-10-23 21:00:21 | 93,665 0 | 93,665 | Form 4 |
| Epperly Melissa B Director | 2024-10-23 21:00:20 | 38,037 0 | 38,037 | Form 4 |
| Fitzgerald Meghan Director | 2024-09-16 21:00:47 | 30,270 0 | 30,270 | Form 4 |
| Tada Masayo Director | 2021-10-01 17:39:52 | 0 0 | 0 | Form 3 |
| Sumitomo Chemical Co. Ltd. Sumitomo Pharma Co. Ltd. 10% Owner | 2024-04-02 16:06:58 | 0 0 | 0 | Form 13G |
| Nomura Hiroshi Director | 2022-09-23 18:00:58 | 0 0 | 0 | Form 3 |